Bevacizumab improves success rate of augmented trabeculectomy for neovascular glaucoma in young diabetic patients

Article

The addition of bevacizumab (Avastin) to trabeculectomy improves the success rate of IOP control, particularly in young diabetic patients with neovascular glaucoma (NVG), according to a study published online, ahead of print, by Eye.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Related Content
A hand writes a check mark in a box. It is superimposed over an image of samples in a laboratory. Image credit: ©everythingpossible – stock.adobe.com

European Commission grants marketing authorisation to aflibercept biosimilar EYLUXVI (ALT-L9)

Martin David Harp
September 17th 2025
Article
Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
September 17th 2025
Podcast
An image of an iris placed over a digital interlay. Concept image for BVI Medical and VirtuaLens new technologies at European Society of Cataract and Refractive Surgeons meeting in Copenhagen, Denmark. (Image credit: ©spainter_vfx/AdobeStock)

BVI, VirtuaLens will showcase new technologies at ESCRS 2025

Kassi Filkins
September 17th 2025
Article
Upcoming company presentations from Alcon, J&J, B+L at ESCRS 2025

Upcoming company presentations from Alcon, J&J, B+L at ESCRS 2025

Kassi Filkins
September 17th 2025
Article
The Intercil Uveal Spacer from Ciliatech, which recently obtained a CE mark, does not penetrate the anterior of the eye. All images courtesy of Ciliatech.

Ciliatech leadership comments on CE mark for novel glaucoma device

Hattie Hayes;Kassi Filkins
September 17th 2025
Article
A photo of Prithvi Ramtohul, MD, who received the Ramin Tadayoni Award at the 2025 EURETINA Congress.

EURETINA grants Prithvi Ramtohul, MD, 2025 Ramin Tadayoni Award

Hattie Hayes
September 17th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.